Envision Healthcare Co. (NYSE:EVHC) Shares Bought by Reinhart Partners Inc.

Reinhart Partners Inc. boosted its stake in Envision Healthcare Co. (NYSE:EVHC) by 27.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 390,358 shares of the company’s stock after buying an additional 84,618 shares during the period. Envision Healthcare accounts for about 2.4% of Reinhart Partners Inc.’s portfolio, making the stock its 14th largest position. Reinhart Partners Inc. owned 0.34% of Envision Healthcare worth $24,464,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. BlackRock Inc. raised its stake in shares of Envision Healthcare by 3,895.0% in the first quarter. BlackRock Inc. now owns 7,197,631 shares of the company’s stock valued at $441,359,000 after buying an additional 7,017,467 shares in the last quarter. Janus Capital Management LLC increased its position in shares of Envision Healthcare by 63.7% in the first quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company’s stock valued at $167,536,000 after buying an additional 1,055,014 shares during the last quarter. Hexavest Inc. acquired a new position in shares of Envision Healthcare during the first quarter valued at about $41,197,000. Vanguard Group Inc. increased its position in shares of Envision Healthcare by 4.0% in the first quarter. Vanguard Group Inc. now owns 11,266,818 shares of the company’s stock valued at $690,881,000 after buying an additional 433,593 shares during the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in shares of Envision Healthcare during the first quarter valued at about $24,833,000. 64.75% of the stock is currently owned by institutional investors and hedge funds.

Envision Healthcare Co. (NYSE:EVHC) traded up 0.23% on Friday, hitting $52.89. The stock had a trading volume of 1,356,946 shares. The stock’s market capitalization is $6.19 billion. The company has a 50-day moving average price of $59.31 and a 200-day moving average price of $61.09. Envision Healthcare Co. has a 52 week low of $51.44 and a 52 week high of $74.75.

Envision Healthcare (NYSE:EVHC) last issued its earnings results on Monday, August 7th. The company reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.04. Envision Healthcare had a positive return on equity of 5.35% and a negative net margin of 7.35%. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. During the same period in the previous year, the company posted $0.34 EPS. The firm’s revenue was up 156.7% compared to the same quarter last year. Equities research analysts anticipate that Envision Healthcare Co. will post $1.40 earnings per share for the current fiscal year.

WARNING: “Envision Healthcare Co. (NYSE:EVHC) Shares Bought by Reinhart Partners Inc.” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2017/08/11/envision-healthcare-corporation-nyseevhc-stake-raised-by-reinhart-partners-inc-updated-updated-updated.html.

EVHC has been the subject of several research analyst reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 price objective on shares of Envision Healthcare in a research report on Tuesday, July 4th. Zacks Investment Research upgraded Envision Healthcare from a “strong sell” rating to a “buy” rating and set a $70.00 price objective for the company in a research report on Tuesday, July 4th. Royal Bank Of Canada restated a “buy” rating and set a $72.00 target price on shares of Envision Healthcare in a research report on Monday, June 5th. Jefferies Group LLC restated a “buy” rating and set a $71.00 target price (down previously from $75.00) on shares of Envision Healthcare in a research report on Wednesday, May 3rd. Finally, Mizuho dropped their target price on Envision Healthcare from $70.00 to $60.00 and set a “neutral” rating for the company in a research report on Tuesday, May 30th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $71.56.

In other Envision Healthcare news, insider Robert Jon Coward sold 1,500 shares of Envision Healthcare stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the transaction, the insider now owns 97,863 shares in the company, valued at approximately $6,135,031.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 3.10% of the stock is currently owned by insiders.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

What are top analysts saying about Envision Healthcare Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Co. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit